ID   ras/mycSFME
AC   CVCL_A6JT
SY   ras/myc SFME
DR   Wikidata; Q107116708
RX   PubMed=2011405;
RX   PubMed=8376308;
CC   Group: Serum/protein free medium cell line.
CC   Transfected with: HGNC; 5173; HRAS (with p.Gly12Val).
CC   Transfected with: MGI; MGI:97250; Myc.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A6JS ! rasSFME
SX   Sex unspecified
AG   16FD
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
RX   PubMed=2011405;
RA   Rawson C.L., Shirahata S., Collodi P., Natsuno T., Barnes D.W.;
RT   "Oncogene transformation frequency of nonsenescent SFME cells is
RT   increased by c-myc.";
RL   Oncogene 6:487-489(1991).
//
RX   PubMed=8376308; DOI=10.1007/BF02634544;
RA   Nomura T., Matano S., Okada G., Tokuyama H., Hori I., Nakamura S.,
RA   Kameyama T., Ryoyama K.;
RT   "Establishment of a metastatic murine cell line carrying the human
RT   C-Ha-ras.";
RL   In Vitro Cell. Dev. Biol. Anim. 29:614-616(1993).
//